Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 3
2005 1
2006 2
2007 5
2008 3
2009 6
2010 6
2011 8
2012 11
2013 7
2014 11
2015 11
2016 5
2017 2
2018 5
2019 10
2020 12
2021 4
2022 10
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Results by year

Filters applied: . Clear all
Page 1
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators. Weller M, et al. Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23. Lancet Oncol. 2017. PMID: 28844499 Free article. Clinical Trial.
Palbociclib and ribociclib in breast cancer: consensus workshop on the management of concomitant medication.
Bellet M, Ahmad F, Villanueva R, Valdivia C, Palomino-Doza J, Ruiz A, Gonzàlez X, Adrover E, Azaro A, Valls-Margarit M, Parra JL, Aguilar J, Vidal M, Martín A, Gavilá J, Escrivá-de-Romaní S, Perelló A, Hernando C, Lahuerta A, Zamora P, Reyes V, Alcalde M, Masanas H, Céliz P, Ruíz I, Gil M, Seguí MÀ, de la Peña L. Bellet M, et al. Among authors: gil m. Ther Adv Med Oncol. 2019 May 10;11:1758835919833867. doi: 10.1177/1758835919833867. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31205497 Free PMC article. Review.
Adjustment for continuous confounders: an example of how to prevent residual confounding.
Groenwold RH, Klungel OH, Altman DG, van der Graaf Y, Hoes AW, Moons KG; PROTECT WP2 (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium, Work Programme 2 [Framework for pharmacoepidemiology studies]). Groenwold RH, et al. CMAJ. 2013 Mar 19;185(5):401-6. doi: 10.1503/cmaj.120592. Epub 2013 Feb 11. CMAJ. 2013. PMID: 23401401 Free PMC article. Review. No abstract available.
Digital quantification of KI-67 in breast cancer.
Del Rosario Taco Sanchez M, Soler-Monsó T, Petit A, Azcarate J, Lasheras A, Artal C, Gil M, Falo C, Pla MJ, Matias-Guiu X. Del Rosario Taco Sanchez M, et al. Among authors: gil m. Virchows Arch. 2019 Feb;474(2):169-176. doi: 10.1007/s00428-018-2481-3. Epub 2018 Nov 21. Virchows Arch. 2019. PMID: 30465110
INTERVENCIONES.
Calero R, De Miguel G. Calero R, et al. Among authors: de miguel g. An R Acad Nac Med (Madr). 2014;131(2):508-10. An R Acad Nac Med (Madr). 2014. PMID: 27400571 Spanish. No abstract available.
108 results